Article
The DNA Repair Enzyme XPD Is Partially Regulated by PI3K/AKT Signaling in the Context of…
Oxidative Medicine and Cellular Longevity · 2021 · Wei Zhao, author Lei Zeng, author Jiaming Luo, author Ji Li, author Luying Lai, author Shiyuan Xu, author Zhongjie Liu, author Xin Luo, Academic Editor
Key facts
| Title | The DNA Repair Enzyme XPD Is Partially Regulated by PI3K/AKT Signaling in the Context of Bupivacaine-Mediated Neuronal DNA Damage |
|---|---|
| First author | Wei Zhao, author Lei Zeng, author Jiaming Luo, author Ji Li, author Luying Lai, author Shiyuan Xu, author Zhongjie Liu, author Xin Luo, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Apr 4, 2021 |
| DOI | 10.1155/2021/9925647 |
| Devices mentioned | 202390, K770049, K800552, K832688, K841744, K843086, K850090, K850092, K850891, K851606, K853723, K860029 and 25 more |
| Product codes mentioned | CFJ, CFN, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JJT and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1